down arrow

Alvotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: LU2458332611
USD
5.07
0.47 (10.22%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Krystal Biotech, Inc.
Blueprint Medicines Corp.
Axsome Therapeutics, Inc.
Arrowhead Pharmaceuticals, Inc.
Intellia Therapeutics, Inc.
CRISPR Therapeutics AG
Alvotech
Prothena Corp. Plc
ImmunoGen, Inc.
Denali Therapeutics, Inc.
Mirati Therapeutics, Inc.
Why is Alvotech ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of 142.90% and Operating profit at 48.15% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -7.56
2
Risky - Negative Book Value
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -55.50%, its profits have risen by 77% ; the PEG ratio of the company is 0.4
3
Below par performance in long term as well as near term
  • Along with generating -55.50% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Alvotech for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Alvotech
-56.33%
-1.01
62.62%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
142.90%
EBIT Growth (5y)
48.15%
EBIT to Interest (avg)
-7.56
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-3.54
Sales to Capital Employed (avg)
0.61
Tax Ratio
4.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.70%
ROCE (avg)
6.75%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
-10.64
EV to EBIT
41.42
EV to EBITDA
31.55
EV to Capital Employed
5.59
EV to Sales
7.62
PEG Ratio
0.42
Dividend Yield
NA
ROCE (Latest)
13.49%
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -42.55 MM

NET SALES(HY)

At USD 306 MM has Grown at 44.91%

NET PROFIT(HY)

Higher at USD 141.72 MM

DEBT-EQUITY RATIO (HY)

Lowest at -644.19 %

DEBTORS TURNOVER RATIO(HY)

Highest at 3.61 times

-7What is not working for the Company
PRE-TAX PROFIT(Q)

At USD 9.31 MM has Fallen at -87.88%

NET PROFIT(Q)

At USD 32.04 MM has Fallen at -50.88%

RAW MATERIAL COST(Y)

Grown by 26.05% (YoY

Here's what is working for Alvotech
Net Sales
At USD 306 MM has Grown at 44.91%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Cash Flow
Highest at USD -42.55 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio
Lowest at -644.19 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 3.61 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Depreciation
Highest at USD 8.9 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Alvotech
Pre-Tax Profit
At USD 9.31 MM has Fallen at -87.88%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD 32.04 MM has Fallen at -50.88%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Raw Material Cost
Grown by 26.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."